We asked 3 VCs: would you invest in Elizabeth Holmes’ next startup? | E2353

Jason Calacanis hosts a venture roundtable with Sam Lessin, Paige Finn Doherty, and Jenny Fielding. They ask whether investors would back Elizabeth Holmes's next startup after Theranos, and debate how much fraud is unavoidable across a seed portfolio. The panel also covers the Valar Atomics pro rata dispute, voice ownership and the ElevenLabs Archer controversy, NIL deals, and founder diligence training. The conversation uses recent fraud cases to map how investors weigh reputational risk against deal economics.